Emergence of HIV-1 Resistance to Dolutegravir In this case report, the emergence of HIV-1 resistance to dolutegravir is identified early after the initiation of antiretroviral treatment.
No takes yet. Share an insight, caveat, or question.
Lübke et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: